Why Drug Price Negotiation Has Staying Power
In this Axios column, Drew Altman looks beyond Medicare to what’s at stake for employers and workers in the debate about the government negotiating drug prices.
View the Latest: Prescription Drugs
Filter
-
-
Health Care Inflation in the U.S.
Event Date:EventThe pressures of inflation are far reaching, affecting providers, insurers, government programs such as Medicaid and Medicare, and, ultimately, the American people. Over the coming months, health care providers and insurers will wrap up pricing negotiations and set premiums for the next year. Amid these negotiations, there remain big questions as to how economic policy and legislation such as the Inflation Reduction Act will influence pricing and payment for insurance and health care, including prescription drugs, and who will bear the brunt of rising costs.
-
Dec. 8 Event: Unpacking the Prescription Drug Provisions of the Build Back Better Act
Event Date:EventAs the Build Back Better Act shifts from the House to the Senate, there’s considerable interest in provisions that would lower the cost of prescription drugs.
-
Why Consumer Issues Are Rising on the Health Agenda
From Drew AltmanIn this column for The Wall Street Journal’s Think Tank, Drew Altman examines the trends that may be leading to a rise in consumer cost issues on the health agenda.
-
-
The 16th Annual Kaiser 50-State Medicaid Budget Survey: Slowing Growth and Evolving Policies at a Forum with the National Association of Medicaid Directors
Event Date:EventAt 9:30 a.m. ET on Thursday, Oct. 13, the Kaiser Family Foundation’s Commission on Medicaid and the Uninsured (KCMU) released Kaiser's 16th annual 50-state Medicaid budget survey for state fiscal years 2016 and 2017.
-
How High Drug Prices Weigh on the Sickest Americans
From Drew AltmanIn this column for The Wall Street Journal's Think Tank, Drew Altman explores the data behind public concern about prescription drug costs and highlights that the people most in need are the most burdened by the problem.
-
Why Painkiller Addiction and Abuse Are Rising Health-Care Priorities
From Drew AltmanIn this column for The Wall Street Journal’s Think Tank, Drew Altman uses new polling to explore why painkiller abuse and addiction is rising as a health issue among state and federal policymakers.
-
Prescription Drug Costs Break Through the Partisan Logjam
From Drew AltmanIn this Axios column, Drew Altman analyzes new poll findings which show how one issue breaks through the gridlock between Democrats and Republicans in health – the high cost of prescription drugs.
-
Weighted Average Monthly Premium for Medicare Part D Stand-alone Prescription Drug Plans
State Health Facts Indicator